Overview

The award is given in recognition of excellence pertaining to the field of internal dosimetry as it relates to nuclear medicine through:

research and/or development.
significant publication contributions; or,
advancement of the understanding of internal dosimetry in relationship to risk and therapeutic efficacy.

The MIRD Committee is seeking suggestions for potential nominees for the Loevinger-Berman Award. Anyone who wishes to make recommendations to the committee should list reasons why the nominee is deserving of the award and include a curriculum vitae and references to relevant publications by the nominee. All recommendations will be carefully considered by the committee. Nominations should be sent with supporting material to Pat Zanzonico, Chair, MIRD Committee, zanzonip@mskcc.org. This award is made possible by funding from the Education and Research Foundation.

AI Based Application Success Predictor

Category	Details
Organization	Society of Nuclear Medicine and Molecular Imaging (SNMMI)
Organization type	Professional medical and scientific society; grant programs are supported by SNMMI and funding partners. SNMMI +1
Government/Federal or Non-Profit/Corporate	Professional non-profit society
Primary research areas	Nuclear medicine, molecular imaging, radiopharmaceuticals, targeted radionuclide therapy, and diagnostic imaging.
Previous success predictors	1. Scientific novelty and innovation. 2. Relevance to nuclear medicine and molecular imaging. 3. Potential for translational research and future external funding. 4. Investigator's research potential and career stage. 5. Methodological rigor and feasibility. 6. Preliminary data and a well-defined research proposal. 7. Relevant qualifications and SNMMI membership, where required. 8. Strong supervisor or mentor recommendations, where required. 9. Clear budget and achievable objectives. 10. Compliance with the specific award's eligibility requirements. CareerOneStop +1
Historical success rate	Not verified; published recipient lists alone do not establish an award success rate.

Excel-ready entry — Previous Success Predictors: Scientific innovation; nuclear medicine and molecular imaging relevance; translational potential; future funding potential; investigator research experience; career stage; methodological rigor; preliminary data; mentor support; feasibility; budget justification; and eligibility compliance.

Note: Specific criteria differ across research grants, student scholarships, fellowships, and professional awards. The predictors above combine published eligibility criteria with general research-funding considerations; they are not a statistically validated ranking of past award outcomes.

Specialties

Nuclear Medicine

Eligibility Requirements

The award is given in recognition of excellence pertaining to the field of internal dosimetry as it relates to nuclear medicine through:

research and/or development.
significant publication contributions; or,
advancement of the understanding of internal dosimetry in relationship to risk and therapeutic efficacy.

Sponsor Details

Sponsor Institute/Organizations: Society of Nuclear Medicine and Molecular Imaging

Sponsor Type: Corporate/Non-Profit

Address: 1850 Samuel Morse Drive Reston, Virginia 20190 P: 703.708.9000

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity